Abecma Europäische Union - Isländisch - EMA (European Medicines Agency)

abecma

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - Æxlishemjandi lyf - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Idotrim Filmuhúðuð tafla 160 mg Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

idotrim filmuhúðuð tafla 160 mg

orion corporation (i)* - trimethoprimum inn - filmuhúðuð tafla - 160 mg

Fucithalmic Augndropar, dreifa 10 mg/g Island - Isländisch - LYFJASTOFNUN (Icelandic Medicines Agency)

fucithalmic augndropar, dreifa 10 mg/g

amdipharm limited* - acidum fusidicum inn - augndropar, dreifa - 10 mg/g